Calcium, dairy products, and risk of prostate cancer in a prospective cohort of United States men

Cancer Epidemiology Biomarkers and Prevention

Volumn 12, Issue 7, 2003, Pages 597-603

  Rodriguez, Carmen ^a   McCullough, Marjorie L ^a   Mondul, Alison M ^a   Jacobs, Eric J ^a   Fakhrabadi Shokoohi, Dorna ^a   Giovannucci, Edward L ^b   Thun, Michael J ^a   Calle, Eugenia E ^a  

^a AMERICAN CANCER SOCIETY   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CALCIUM; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CALCIUM INTAKE; CANCER RISK; CELL PROLIFERATION; COHORT ANALYSIS; DAIRY PRODUCT; DIET; DIET SUPPLEMENTATION; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; UNITED STATES;

AGED; CALCIUM, DIETARY; DAIRY PRODUCTS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; QUESTIONNAIRES; RISK FACTORS; TIME FACTORS; UNITED STATES;

EID: 0041846629     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Chan, J. M., Giovannucci, E., Andersson, S-O., Yuen, J., Adami, H.O., and Wolk, A. Dairy products, calcium, phosphorous, vitamin D, and risk of prostate cancer. Cancer Causes Control, 9: 559-566, 1998.
2. Hayes, R. B., Ziegler, R. G., Gridley, G., Swanson, C., Greenberg, R. S., Swanson, G. M., Schoenberg, J. B., Silverman, D. T., Brown, L. M., Pottem, L. M., Liff, J., Schwartz, A. G., Fraumeni, J. F., and Hoover, R. N. Dietary factors and risks of prostate cancer among blacks and whites in the United States. Cancer Epidemiol. Biomark. Prev., 8: 25-34, 1999.
3. Tzonou, A., Signorello, L., Laiou, P., Wu, J., Trichopoulos, D., and Trichopoulou, A. Diet and cancer of the prostate: a case-control study in Greece. Int. J. Cancer, 80: 704-708, 1999.
4. Kristal, A., Cohen, J. H., Qu, P., and Stanford, J. L. Associations of energy, fat, calcium, and vitamin D with prostate cancer risk. Cancer Epidemiol. Biomark. Prev., 11: 719-725, 2002.
5. Ohno, Y., Yoshida, O., Oishi, K., Okada, K., Yamabe, H., and Schroeder, F. H. Dietary β-carotene and cancer of the prostate: a case-control study in Kyoto, Japan. Cancer Res., 48: 1331-1336, 1988.
6. Vlajinac, H., Marinkovic, J., Ilic, M., and Kocev, N. Diet and prostate cancer: a case-control study. Eur. J. Cancer, 33: 101-107, 1997.
7. Giovannucci, E., Rimm, E. B., Wolk, A., Ascherio, A., Stampfer, M. J., Colditz, G. A., and Willett, W. C. Calcium and fructose intake in relation to risk of prostate cancer. Cancer Res., 58: 442-447, 1998.
8. Chan, J. M., Stampfer, M. J., Ma, J., Gann, P. H., Gaziano, J. M., and Giovannucci, E. Dairy products, calcium, and prostate cancer risk in the Physicians' Health Study. Am. J. Clin. Nutr., 74: 549-554, 2001.
9. Chan, J. M., Pietinen, P., Virtanen, M., Malila, N., and Tangrea, J. Diet and prostate cancer risk in a cohort of smokers, with specific focus on calcium and phosphorus (Finland), Cancer Causes Control, 11: 859-867, 2000.
10. Schuurman, A. G., van den Brandt, P. A., Dorant, E., and Goldbohm, R. A. Animal products, calcium and protein and prostate cancer risk in the Netherlands Cohort study. Br. J. Cancer, 80: 1107-1113, 1999.
11. Talamini, R., La Vecchia, C., Decarli, A., Negri, E., and Franceschi, S. Nutrition, social factors, and prostatic cancer in a Northern Italian population. Br. J. Cancer, 53: 817-821, 1986.
12. Mettlin, C., Selenskas, S., Natarajan, N. S., and Huben, R. β-Carotene and animal fats and their relationship to prostate cancer risk: a case-control study. Cancer (Phila.), 64: 605-612, 1989.
13. La Vecchia, C., Negri, E., D'Avanzo, B., Franceschi, S., and Boyle, P. Dairy products and the risk of prostatic cancer. Oncology, 48: 406-410, 1991.
14. Talamini, R., Franceschi, S., La Vecchia, C., Serraino, D., Barra, S., and Negri, E. Diet and prostatic cancer: a case-control study in Northern Italy. Nutr. Cancer, 18: 277-286, 1992.
15. De Stefani, E., Fierro, L., Barrios, E., and Ronco, A. Tobacco, alcohol, diet and risk of prostate cancer. Tumori, 81: 315-320, 1995.
16. Jain, M., Hislop, G., Howe, G., and Ghadirian, P. Plant foods, antioxidants, and prostate cancer risk: findings from case-control studies in Canada. Nutr. Cancer, 34: 173-184, 1999.
17. Rotkin, I. D. Studies in the epidemiology of prostatic cancer: expanded sampling. Cancer Treat. Rep., 61: 173-180, 1977.
18. Schuman, L. M., Mandel, J. S., Radke, A., Seal, U., and Halberg, F. Some selected features of the epidemiology of prostatic cancer: Minneapolis-St. Paul, Minnesota case-control study, 1976-1979. Trends in Cancer Incidence: Causes and Practical Implications. Washington DC: Hemisphere Publishing, 345-354, 1982.
19. Whittemore, A., Kolonel, L., Wu, A., John, E., Gallagher, R., Howe, G., Burch, J., Hankin, J., Dreon, D., West, D., Teh, C-Z., and Paffenbarger, R. Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada. J. Natl. Cancer Inst. (Bethesda), 87: 652-661, 1995.
20. Ewings, P., and Bowie, C. A case-control study of cancer of the prostate in Somerset and east Devon. Br. J. Cancer, 74: 661-666, 1996.
21. Deneo-Pellegrini, H., De Stefani, E., Ronco, A., and Mendilaharsu, M. Foods, nutrients and prostate cancer: a case-control study in Uruguay. Br. J. Cancer, 80: 591-597, 1999.
22. Severson, R. K., Nomura, A. M. Y., Grove, J. S., and Stemmermann, G. N. A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii. Cancer Res., 49: 1857-1860, 1989.
23. Le Marchand, L., Kolonel, L. N., Wilkens, L. R., Myers, B. C., and Hirohata, T. Animal fat consumption and prostate cancer: a prospective study in Hawaii. Epidemiology, 5: 276-282, 1994.
24. Chan, J., and Giovannucci, E. Dairy products, calcium, and vitamin D and risk of prostate cancer. Epidemiol. Rev., 23: 87-92, 2001.
25. Mills, P. K., Beeson, W. L., Phillips, R. L., and Fraser, G. E. Cohort study of diet, lifestyle, and prostate cancer in Adventist men. Cancer (Phila.), 64: 598-604, 1989.
26. Hsing, A. W., McLaughlin, J. K., Schuman, L. M., Bjelke, E., Gridley, W., Wacholder, S., Chien, H. T., and Blot, W. J. Diet, tobacco use, and fatal prostate cancer: results from the Lutheran Brotherhood Cohort Study. Cancer Res., 50: 6836-6840, 1990.
27. Lokeshwar, B., Schwartz, G., Selzer, M., Burnstein, K., Zhuang, S.-H., Block, N., and Binderup, L. Inhibition of prostate cancer metastasis in vivo: a comparison of 1,25-Dihydroxyvitamin D (Calcitrol) and EB 1089. Cancer Epidemiol. Biomark. Prev., 8: 249-253, 1999.
28. Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride/Standing Committee on the Scientific Evaluation of Dietary References Intakes, Foods and Nutrition Board. National Academy of Press. Washington, DC: Institute of Medicine, 1977.
29. United States Department of Agriculture. Continuing Survey of Food Intakes by Individuals: Agricultural Research Services, 1998.
30. Wu, K., Willett, W., Fuchs, C., Colditz, G., and Giovannucci, E. Calcium intake and risk of colon cancer in women and men. J. Natl. Cancer Inst. (Bethesda), 94: 437-446, 2002.
31. Dawson-Hughes, B., Harris, S., Krall, E., and Dallal, G. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N. Engl. J. Med., 337: 670-676, 1997.
32. Stellman, S. D., and Garfinkel, L. Smoking habits and tar levels in a new American Cancer Society prospective study of 1.2 million men and women. J. Natl. Cancer Inst. (Bethesda), 76: 1057-1063, 1986.
33. Calle, E. The American Cancer Society Nutrition Survey: rationale, study design, and baseline characteristics. Cancer (Phila.), 94: 2490-2501, 2002.
34. Bergman, M., Calle, E., Mervis, C., Miracle-McMahill, H., Thun, M., and Heath, C. Validity of self-reported cancers in a prospective cohort study in comparison with data from state cancer registries. Am. J. Epidemiol., 147: 556-562, 1998.
35. Calle, E. E., and Terrell, D. D. Utility of the National Death Index for ascertainment of mortality among Cancer Prevention Study II participants. Am. J. Epidemiol., 137: 235-241, 1993.
36. Block, G., Hartman, A. M., Naughton, D. A reduced dietary questionnaire: development and validation. Epidemiology, 1: 58-64, 1990.
37. Block, G., Coyl, L., Smucker, R., and Harlan, L. Health Habits and History Questionnaire: diet history and other risk factors. Personal computer system documentation. Bethesda, MD: National Cancer Institute Division of Cancer Prevention and Control, National Institute of Health, 1989.
38. Willett, W., and Stampfer, M. Total energy intake: implications for epidemiologic analyses. Am. J. Epidemiol., 124: 17-27, 1986.
39. Flagg, E., Coates, R., Calle, E., Potischman, N., and Thun, M. Validation of the American Cancer Society Cancer Prevention Study II Nutrition survey cohort food frequency questionnaire. Epidemiology, 11: 462-468, 2000.
40. Agricultural Research Service. Provisional table on vitamin D content of foods. Beltsville, MD: United States Department of Agriculture, 1991.
41. Giovannucci, E. Is the androgen receptor CAG repeat length significant for prostate cancer? Cancer Epidemiol. Biomark. Prev., 11: 985-986, 2002.
42. Institute of Medicine. Dietary references intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride. Washington, DC: Institute of Medicine, 1997.
43. Schwartz, G., Wang, M-H., Zhang, M., Singh, R., and Siegal, G. 1á,25-Dihydroxyvitamin D (Calcitriol) inhibits the invasiveness of human prostate cancer cells. Cancer Epidemiol. Biomark. Prev., 6: 727-732, 1997.
44. 3 receptors and actions in human prostate cancer cell lines. Endocrinology, 132: 1952-1960, 1993.
45. Miller, G., Stapleton, G., Hedlund, T., and Moffatt, K. Vitamin D receptor expression, 24-hydroxylase activity, and inhibition of growth by 1-α,25-dihydroxyvitamin D in seven human prostatic carcinoma cell lines. Clin. Cancer Res., 1: 997-1003, 1995.
46. Feldman, D., Skowronski, G., and Peehl, D. Vitamin D and prostate cancer. In: American Institute for Cancer Research (ed.), Diet and Cancer: Molecular Mechanisms of Interactions, pp. 53-63. New York, NY: Plenum Press, 1995.
47. 3 and prostate cancer cell proliferation in vivo. Urology, 46: 365-369, 1995.
48. Lucia, M., Anzano, M., and Slayter, M. Chemopreventive activity of tamoxifen, N-(4-hydroxyphenyl) retinnamide, and the vitamin D analogue Ro24-5531 for androgen-promoted carcinomas of the rat seminal vesicle and prostate. Cancer Res., 55: 5621-5627, 1995.
49. Corder, E., Guess, H., Hulka, B., Friedman, G., Sadler, M., Vollmer, R., Lobaugh, B., Drezner, M., Vogelman, J., and Orentreich, N. Vitamin D and prostate cancer: a prediagnostic study with stored sera. Cancer Epidemiol. Biomark. Prev., 2: 467-472, 1993.
50. Braun, M. M., Helzlsouer, K. J., Hollis, B. W., and Comstock, G. W. Prostate cancer and prediagnostic levels of serum vitamin D metabolites (Maryland, United States). Cancer Causes Control, 6: 235-239, 1995.
51. Gann, P. H., Ma, J., Hennekens, C. H., Hollis, B. W., Haddad, J. G., and Stampfer, M. J. Circulating vitamin D metabolites in relation to subsequent development of prostate cancer. Cancer Epidemiol. Biomark. Prev., 5: 121-126. 1996.
52. Nomura, A. M. Y., Stemmermann, G. N., Lee, J., Kolonel, L. N., Chen, T. C., Turner, A., and Holick, M. F. Serum Vitamin D metabolite levels and the subsequent development of prostate cancer (Hawaii, United States). Cancer Causes Control, 9: 425-432, 1998.
53. 3, inhibits the proliferation of primary prostatic epithelial cells. Cancer Epidemiol. Biomark. Prev., 9: 265-270, 2000.
54. Chan, J., Stampfer, M., Ma, J., Gann, P., Gaziano, M., Pollak, M., and Giovannucci, E. Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer. J. Natl. Cancer Inst. (Bethesda), 94: 1099-1109, 2002.
55. Heaney, R., McCarron, D., Dawson-Hughes, B., Oparil, S., Berga, S., Stem, J., Barr, S., and Rosen, C. Dietary changes favorably affect bone remodeling in older adults. J. Am. Diet. Assoc., 99: 1228-1233, 1999.
56. Chan, J., Stampfer, M., Giovannucci, E., Gann, P., Wilkinson, P., Hennekens, C., and Pollak, M. Plasma insulin-like growth factor-1 and prostate cancer risk; a prospective study, Science (Wash. DC), 279: 563-566, 1998.